New use of polyunsaturated lecithin


Application Number: 00108743
Application Date: 2000.06.02
Publication Number: 1326744
Publication Date: 2001.12.19
Priority Information:
International: A61K31/662;A61K31/80;A61P1/16;A61P9/00
Applicant(s) Name: Huajingshibi High Science and Technology Development Co., Ltd., Beijing
Address:
Inventor(s) Name: Thomas Wennich
Patent Agency Code: 11038
Patent Agent: yang hongjun
Abstract The present invention provides the new application of polyunsaturated lecitin in preparing blood vessen endodermis growth factor expression inhibitor and especially in preparing liver diseases treating agent. The blood vessel endodermis growth factor expression inhibitor containing the polyunsaturated lecithin can reduce the blood vessel endodermis growth factor expression level excited in the damaged liver tissue and inhibit the blood vessel hyperplasia of the liver tissue.